Chemokine Fractalkine Attenuates Overactivation and Apoptosis of BV-2 Microglial Cells Induced by Extracellular ATP

[1]  D. Geschwind,et al.  Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and Δ9‐tetrahydrocannabinol in BV‐2 microglial cells , 2012, British journal of pharmacology.

[2]  Sufen Yang,et al.  Clozapine Protects Dopaminergic Neurons from Inflammation-Induced Damage by Inhibiting Microglial Overactivation , 2012, Journal of Neuroimmune Pharmacology.

[3]  P. Bickford,et al.  CX3CR1 Deficiency Leads to Impairment of Hippocampal Cognitive Function and Synaptic Plasticity , 2011, The Journal of Neuroscience.

[4]  B. Fredholm,et al.  CX3CL1 Is Neuroprotective in Permanent Focal Cerebral Ischemia in Rodents , 2011, The Journal of Neuroscience.

[5]  C. Glass,et al.  Microglial cell origin and phenotypes in health and disease , 2011, Nature Reviews Immunology.

[6]  C. Matute,et al.  Glutamate and Atp Signalling in White Matter Pathology , 2022 .

[7]  K. Suk,et al.  Inhibitors of Microglial Neurotoxicity: Focus on Natural Products , 2011, Molecules.

[8]  P. Bickford,et al.  CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson's disease , 2011, Journal of Neuroinflammation.

[9]  A. Suzumura,et al.  Fractalkine Attenuates Excito-neurotoxicity via Microglial Clearance of Damaged Neurons and Antioxidant Enzyme Heme Oxygenase-1 Expression* , 2010, The Journal of Biological Chemistry.

[10]  E. Polazzi,et al.  Microglia and neuroprotection: From in vitro studies to therapeutic applications , 2010, Progress in Neurobiology.

[11]  Richard M. Page,et al.  Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease , 2010, Nature Neuroscience.

[12]  Shijie Jin,et al.  Glutamate induces neurotrophic factor production from microglia via protein kinase C pathway , 2010, Brain Research.

[13]  Su Jin Lee,et al.  Suppression of inducible nitric oxide synthase and cyclooxygenase-2 by cell-permeable superoxide dismutase in lipopolysaccharide-stimulated BV-2 microglial cells , 2010, Molecules and cells.

[14]  F. Heppner,et al.  Neuroprotective function for ramified microglia in hippocampal excitotoxicity , 2012, Journal of Neuroinflammation.

[15]  M. Lynch,et al.  Fractalkine‐induced activation of the phosphatidylinositol‐3 kinase pathway attentuates microglial activation in vivo and in vitro , 2009, Journal of neurochemistry.

[16]  H. Daniel,et al.  Neural progenitor cell death is induced by extracellular ATP via ligation of P2X7 receptor , 2009, Journal of neurochemistry.

[17]  Peter Ponsaerts,et al.  Microglia: gatekeepers of central nervous system immunology , 2009, Journal of leukocyte biology.

[18]  H. Neumann,et al.  Debris clearance by microglia: an essential link between degeneration and regeneration , 2008, Brain : a journal of neurology.

[19]  C. Limatola,et al.  Activity of Adenosine Receptors Type 1 Is Required for CX3CL1-Mediated Neuroprotection and Neuromodulation in Hippocampal Neurons1 , 2008, The Journal of Immunology.

[20]  K. Suk,et al.  A Dual Role of Lipocalin 2 in the Apoptosis and Deramification of Activated Microglia1 , 2007, The Journal of Immunology.

[21]  A. Pérez-Samartín,et al.  Excitotoxic damage to white matter , 2007, Journal of anatomy.

[22]  P. Monk,et al.  ALS: life and death in a bad neighborhood , 2006, Nature Medicine.

[23]  S. Przedborski,et al.  Fractalkine: moving from chemotaxis to neuroprotection , 2006, Nature Neuroscience.

[24]  Steffen Jung,et al.  Control of microglial neurotoxicity by the fractalkine receptor , 2006, Nature Neuroscience.

[25]  H. Kettenmann,et al.  Purinergic signaling and microglia , 2006, Pflügers Archiv.

[26]  G. Burnstock,et al.  Purinergic signalling in neuron–glia interactions , 2006, Nature Reviews Neuroscience.

[27]  T. Möller,et al.  Microglia Biology in Health and Disease , 2006, Journal of Neuroimmune Pharmacology.

[28]  Jongseo Lee,et al.  15,16-Dihydrotanshinone I suppresses the activation of BV-2 cell, a murine microglia cell line, by lipopolysaccharide , 2006, Neurochemistry International.

[29]  G. Burnstock,et al.  Microglial morphology and its transformation after challenge by extracellular ATP in vitro , 2006, Journal of neuroscience research.

[30]  M. Hannink,et al.  Distinct signaling pathways for induction of type II NOS by IFNγ and LPS in BV-2 microglial cells , 2005, Neurochemistry International.

[31]  F. Eusebi,et al.  Chemokine CX3CL1 protects rat hippocampal neurons against glutamate-mediated excitotoxicity , 2005, Journal of Neuroimmunology.

[32]  W. Gan,et al.  ATP mediates rapid microglial response to local brain injury in vivo , 2005, Nature Neuroscience.

[33]  J. Freyssinet,et al.  Fractalkine reduces N‐methyl‐d‐aspartate‐induced calcium flux and apoptosis in human neurons through extracellular signal‐regulated kinase activation , 2004, The European journal of neuroscience.

[34]  I. Han,et al.  TGF-β1 Represses Activation and Resultant Death of Microglia via Inhibition of Phosphatidylinositol 3-Kinase Activity1 , 2004, The Journal of Immunology.

[35]  A. Suzumura,et al.  Production and neuroprotective functions of fractalkine in the central nervous system , 2003, Brain Research.

[36]  S. Koizumi,et al.  Mechanisms underlying extracellular ATP‐evoked interleukin‐6 release in mouse microglial cell line, MG‐5 , 2001, Journal of neurochemistry.

[37]  Jau-Shyong Hong,et al.  Molecular consequences of activated microglia in the brain: overactivation induces apoptosis , 2001, Journal of neurochemistry.

[38]  K. Bacon,et al.  The Chemokine Fractalkine Inhibits Fas-Mediated Cell Death of Brain Microglia , 2000, Journal of Immunology.

[39]  C. Carter,et al.  Fractalkine modulates TNF‐α secretion and neurotoxicity induced by microglial activation , 2000 .

[40]  F. Bistoni,et al.  Immortalization of murine microglial cells by a v-raf / v-myc carrying retrovirus , 1990, Journal of Neuroimmunology.

[41]  M. Block,et al.  Microglia-mediated neurotoxicity: uncovering the molecular mechanisms , 2007, Nature Reviews Neuroscience.

[42]  Yoichi Nakamura.  Regulating factors for microglial activation. , 2002, Biological & pharmaceutical bulletin.

[43]  J. Bénavidès,et al.  Fractalkine modulates TNF-alpha secretion and neurotoxicity induced by microglial activation. , 2000, Glia.